Global Clinical Grade Disinfectant Market Overview:
Disinfectant Clinical Grade is formulated with two powerful germicides providing a very fast knockdown of gram-positive and gram-negative bacteria. Clinical grade disinfectants are used extensively in doctors’ offices, hospitals, dentists’ offices, medical clinics, and other medical facilities to eliminate dangerous bacteria and viruses from critical surfaces that come into contact with both patients and doctors. Clinical grade disinfectant used as a spray and wipe or floor mopping. It is also used for non-porous hard surfaces like walls, floors, chairs, tables, countertops, display areas, rubbish bins, toilets, urinals, etc. The rising prevalence of Hospital-acquired Infections (HAIs) and increasing government support for probe disinfection will boost the market demand in the forecasted period.
Growth Drivers
- Rise in Number of Highly Contagious Viral Diseases such as H1N1, and COVID-19
- Growing Awareness about Cleanliness and the Need for Disinfection
- Stringent Government Policies on Disinfecting and Sterilizing Medical Facilities
Market Trends
- Increase in the Number of R&D Centers across the Globe
- Greater Awareness of Sanitation as well as Hygiene
Roadblocks
- Fluctuations in the Raw Material Prices
Opportunities
- Increasing Government Initiative for Cleanliness and Disinfection
- Growing Incidents of Infectious and Human-Transmitted Diseases, Particularly Within Healthcare Workers
Challenges
- Emerging players in the clinical grade disinfectant
- Increasing Competition in the Market
Competitive Landscape:
The global Clinical Grade Disinfectant market seems to be fragmented due to the existence of some established and local players in makers and is quite competitive. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings.
Some of the key players profiled in the report are DuPont (United States), BASF SE (Germany), Clariant AG (Switzerland), Lanxess AG (Germany), Ecolab, Inc. (United States), Solvay SA (Belgium), Lonza Group (Switzerland), Microban International, Ltd. (United States), Dow Chemical (United States), Milliken & Company (United States) and Stepan Company (United States). Additionally, following companies can also be profiled that are part of our coverage like Bio-Cide International Inc. (United States), Zep Inc. (United States) and Diversey, Inc. (United States). Analyst at AMA Research see United States Vendors to retain maximum share of Global Clinical Grade Disinfectant market by 2026. Considering Market by Formulation, the sub-segment i.e. Chlorine Compounds will boost the Clinical Grade Disinfectant market. Considering Market by Sales Channel, the sub-segment i.e. Direct Sales will boost the Clinical Grade Disinfectant market.
Latest Market Insights:
In June 2018, Johnson & Johnson received a binding offer from Fortive Corporation to acquire its Advanced Sterilization Products business—a part of Ethicon, Inc.
In the United States, chemical germicides formulated as sanitizers, disinfectants, or sterilants are regulated in interstate commerce by the Antimicrobials Division, Office of Pesticides Program, EPA, under the authority of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) of 1947, as amended 792. Under FIFRA, any substance or mixture of substances intended to prevent, destroy, repel, or mitigate any pest (including microorganisms but excluding those in or on living humans or animals) must be registered before sale or distribution. To obtain a registration, a manufacturer must submit specific data about the safety and effectiveness of each product.
What Can be Explored with the Clinical Grade Disinfectant Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Clinical Grade Disinfectant Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Clinical Grade Disinfectant
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clinical Grade Disinfectant market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clinical Grade Disinfectant market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Clinical Grade Disinfectant, Distributors & Suppliers of Clinical Grade Disinfectant, Raw Material Suppliers, Research Institutes and Academic Centers, Government Associations, Market Research and Consulting Firms, Venture Capitalists and Investors and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.